- Presentations
- 3
- Markets
- 1
Oxbryta is a brand of Voxelotor marketed by Global Blood Therapeutics, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Voxelotor
- Brand owner
- Global Blood Therapeutics
- Registered in
- United States
- Strengths and forms
- 300 mg tablet, 500 mg tablet, 300 mg tablet for oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Oxbryta 300 mg tabletOral | Global Blood Therapeutics | US FDA | Available on request |
| Oxbryta 500 mg tabletOral | Global Blood Therapeutics | US FDA | Available on request |
| Oxbryta 300 mg tablet for oral suspensionOral | Global Blood Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Oxbryta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.